| Everolimus |
15809/29.12.2006 г. |
Certican, Tablet, 0.5, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
300.67 |
60.13 |
360.8 |
4% |
10 |
310.67 |
62.13 |
372.8 |
16% |
25 |
335.67 |
67.13 |
402.8 |
|
НСР-6489/18.06.2015; НСР-12013/20.03.2017; НСР-18949/13.06.2019 |
28.06.2019 |
02.07.2019 |
Активен |
2775 |
| Everolimus |
15809/29.12.2006 г. |
Certican, Tablet, 0.5, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
300.67 |
60.13 |
360.8 |
4% |
10 |
310.67 |
62.13 |
372.8 |
16% |
25 |
335.67 |
67.13 |
402.8 |
|
НСР-6489/18.06.2015; НСР-12013/20.03.2017; НСР-18949/13.06.2019 |
28.06.2019 |
02.07.2019 |
Неактивен |
2775 |
| Everolimus |
15807/29.12.2006 г. |
Certican, Tablet, 0.25, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
167.01 |
33.4 |
200.41 |
4% |
6.68 |
173.69 |
34.74 |
208.43 |
16% |
25 |
198.69 |
39.74 |
238.43 |
|
НСР-6787/23.07.2015; НСР-10454/29.09.2016 |
14.10.2016 |
02.11.2016 |
Неактивен |
3401 |
| Everolimus |
15809/29.12.2006 г. |
Certican, Tablet, 0.5, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
334.04 |
66.81 |
400.85 |
4% |
10 |
344.04 |
68.81 |
412.85 |
16% |
25 |
369.04 |
73.81 |
442.85 |
|
НСР-6489/18.06.2015; НСР-12013/20.03.2017 |
04.04.2017 |
02.05.2017 |
Неактивен |
2775 |
| Everolimus |
15809/29.12.2006 г. |
Certican, Tablet, 0.5, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
334.08 |
66.82 |
400.9 |
4% |
10 |
344.08 |
68.82 |
412.9 |
16% |
25 |
369.08 |
73.82 |
442.9 |
|
НСР-6489/18.06.2015 |
04.07.2015 |
04.07.2015 |
Неактивен |
2775 |
| Everolimus |
15807/29.12.2006 г. |
Certican, Tablet, 0.25, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
167.05 |
33.41 |
200.46 |
4% |
6.68 |
173.73 |
34.75 |
208.48 |
16% |
25 |
198.73 |
39.75 |
238.48 |
|
НСР-6787/23.07.2015 |
08.08.2015 |
08.08.2015 |
Неактивен |
3401 |
| Everolimus |
15807/29.12.2006 г. |
Certican, Tablet, 0.25, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
174.01 |
34.8 |
208.81 |
4% |
6.96 |
180.97 |
36.19 |
217.16 |
16% |
25 |
205.97 |
41.19 |
247.16 |
|
НСР-5148/27.11.2014 |
11.12.2014 |
11.12.2014 |
Неактивен |
3401 |
| Everolimus |
15809/29.12.2006 г. |
Certican, Tablet, 0.5, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
355.37 |
71.07 |
426.44 |
4% |
10 |
365.37 |
73.07 |
438.44 |
16% |
25 |
390.37 |
78.07 |
468.44 |
|
НСР-3428/30.04.2014 |
22.05.2014 |
22.05.2014 |
Неактивен |
2775 |
| Everolimus |
15807/29.12.2006 г. |
Certican, Tablet, 0.25, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
177.71 |
35.54 |
213.25 |
4% |
7.11 |
184.82 |
36.96 |
221.78 |
16% |
25 |
209.82 |
41.96 |
251.78 |
|
НСР-1425/10.10.2013 |
25.10.2013 |
25.10.2013 |
Неактивен |
3401 |
| Everolimus |
15809/29.12.2006 г. |
Certican, Tablet, 0.5, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
355.39 |
71.08 |
426.47 |
4% |
10 |
365.39 |
73.08 |
438.47 |
16% |
25 |
390.39 |
78.08 |
468.47 |
|
КЦРР-2401/21.02.2013 |
12.03.2013 |
12.03.2013 |
Неактивен |
2775 |
| Everolimus |
15806/29.12.2006 г. |
Certican, Tablet, 0.75, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Германия |
600.62 |
120.12 |
720.74 |
4% |
10 |
610.62 |
122.12 |
732.74 |
16% |
25 |
635.62 |
127.12 |
762.74 |
цената се заличава КЦРР-1657/20.11.2012 |
КЦРР-920/04.07.2012 |
19.07.2012 |
19.07.2012 |
Заличен |
1289 |
| Everolimus |
15807/29.12.2006 г. |
Certican, Tablet, 0.25, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
199.44 |
39.89 |
239.33 |
4% |
7.98 |
207.42 |
41.48 |
248.9 |
16% |
25 |
232.42 |
46.48 |
278.9 |
|
КЦРР-920/04.07.2012 |
19.07.2012 |
19.07.2012 |
Неактивен |
3401 |
| Everolimus |
15806/29.12.2006 г. |
Certican, Tablet, 0.75, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Германия |
629.78 |
125.96 |
755.74 |
6% |
15 |
644.78 |
128.96 |
773.74 |
18% |
30 |
674.78 |
134.96 |
809.74 |
|
КЦ-531/19.02.2009 |
13.03.2009 |
13.03.2009 |
Неактивен |
1289 |
| Everolimus |
15809/29.12.2006 г. |
Certican, Tablet, 0.5, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
421.72 |
84.34 |
506.06 |
4% |
10 |
431.72 |
86.34 |
518.06 |
16% |
25 |
456.72 |
91.34 |
548.06 |
|
КЦ-269/05.11.2008 |
21.11.2008 |
21.11.2008 |
Неактивен |
2775 |
| Everolimus |
15807/29.12.2006 г. |
Certican, Tablet, 0.25, mg, Pack: 60 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Germany |
211.6 |
42.32 |
253.92 |
6% |
12.7 |
224.3 |
44.86 |
269.16 |
18% |
30 |
254.3 |
50.86 |
305.16 |
|
КЦ-269/05.11.2008 |
21.11.2008 |
21.11.2008 |
Неактивен |
3401 |
| Metoclopramide |
20010730 |
CERUCAL, Tablet, 10, mg, Pack: 50 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
2.74 |
0.55 |
3.29 |
7% |
0.19 |
2.93 |
0.59 |
3.52 |
20% |
0.55 |
3.48 |
0.7 |
4.18 |
КЦPP-814/15.06.2012 промяна на обстоятелства; промяна на обстоятелства НСР-1867/27.11.2013 |
КЦ-578/23.02.2009; НСР-9288/05.05.2016 |
02.06.2016 |
02.06.2016 |
Заличен |
546 |
| Metoclopramide |
II-13540/22.06.2006 |
CERUCAL, Tablet, 10, mg, Pack: 50 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
2.74 |
0.55 |
3.29 |
7% |
0.19 |
2.93 |
0.59 |
3.52 |
20% |
0.55 |
3.48 |
0.7 |
4.18 |
КЦPP-814/15.06.2012 промяна на обстоятелства; промяна на обстоятелства НСР-1867/27.11.2013 |
КЦ-578/23.02.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
546 |
| Papillomavirus (Human Types 16, 18) |
EU/1/07/419/005 |
Cervarix, Suspension for injection, 1 dose (0,5 ml), -, Pack: 1 pre-filled syringe + 2 needles |
GlaxoSmithKline Biologicals S.A., Белгия |
Glaxo Smith Kline BOILOGICALS sa, Belgium |
88.89 |
17.78 |
106.67 |
4% |
3.56 |
92.45 |
18.49 |
110.94 |
16% |
14.22 |
106.67 |
21.33 |
128 |
|
НСР-3176/07.04.2014 |
21.04.2014 |
21.04.2014 |
Активен |
2683 |
| Papillomavirus (Human Types 16, 18) |
EU/1/07/419/005 |
Cervarix, Suspension for injection, 1 dose (0,5 ml), -, Pack: 1 pre-filled syringe + 2 needles |
GlaxoSmithKline Biologicals S.A., Белгия |
Glaxo Smith Kline BOILOGICALS sa, Belgium |
88.89 |
17.78 |
106.67 |
4% |
3.56 |
92.45 |
18.49 |
110.94 |
16% |
14.22 |
106.67 |
21.33 |
128 |
|
НСР-3176/07.04.2014 |
21.04.2014 |
21.04.2014 |
Неактивен |
2683 |
| Papillomavirus (Human Types 16, 18) |
20100408 |
Cervarix, Suspension for injection, Human Papillomavirus type 16 L1 protein - 20μg Human Papillomavirus type 18 L1 protein - 20μg, mg, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
Glaxo Smith Kline BOILOGICALS sa, Belgium |
105.71 |
21.14 |
126.85 |
4% |
4.23 |
109.94 |
21.99 |
131.93 |
16% |
16.91 |
126.85 |
25.37 |
152.22 |
|
КЦРР-1734/04.12.2012 г |
24.01.2013 |
24.01.2013 |
Неактивен |
2683 |
| Papillomavirus (Human Types 16, 18) |
EU/1/07/419/005 |
Cervarix, Suspension for injection, Human Papillomavirus type 16 L1 protein - 20μg Human Papillomavirus type 18 L1 protein - 20μg, mg, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals S.A, Belgium |
195.58 |
39.12 |
234.7 |
4% |
7.82 |
203.4 |
40.68 |
244.08 |
16% |
25 |
228.4 |
45.68 |
274.08 |
|
КЦ-328/28.11.2008 |
22.12.2008 |
22.12.2008 |
Неактивен |
2683 |
| Cetrorelix |
EU/1/99/100/002 |
Cetrotide, Powder and solvent for solution for injection, 0.25, mg, Pack: 7 |
Merck Europe B.V., Нидерландия |
Baxter Oncology GmbH, Германия |
285.32 |
57.06 |
342.38 |
4% |
10 |
295.32 |
59.06 |
354.38 |
16% |
25 |
320.32 |
64.06 |
384.38 |
Промяна на обстоятелства НСР-19712/29.08.2019 |
НСР-5506/23.01.2015; НСР-15341/30.03.2018; НСР-17561/20.12.2018 |
04.01.2019 |
02.10.2019 |
Активен |
3514 |
| Cetrorelix |
EU/1/99/100/002 |
Cetrotide, Powder and solvent for solution for injection, 0.25, mg, Pack: 7 |
Serono Europe Ltd., Обединено Кралство |
Baxter Oncology GmbH, Германия |
285.32 |
57.06 |
342.38 |
4% |
10 |
295.32 |
59.06 |
354.38 |
16% |
25 |
320.32 |
64.06 |
384.38 |
|
НСР-5506/23.01.2015; НСР-15341/30.03.2018; НСР-17561/20.12.2018 |
04.01.2019 |
02.02.2019 |
Неактивен |
3514 |
| Cetrorelix |
EU/1/99/100/002 |
Cetrotide, Powder and solvent for solution for injection, 0.25, mg, Pack: 7 |
Serono Europe Ltd., Обединено Кралство |
Baxter Oncology GmbH, Германия |
286.53 |
57.31 |
343.84 |
4% |
10 |
296.53 |
59.31 |
355.84 |
16% |
25 |
321.53 |
64.31 |
385.84 |
|
НСР-5506/23.01.2015; НСР-15341/30.03.2018 |
14.04.2018 |
02.05.2018 |
Неактивен |
3514 |
| Cetrorelix |
EU/1/99/100/002 |
Cetrotide, Powder and solvent for solution for injection, 0.25, mg, Pack: 7 |
Serono Europe Ltd., Обединено Кралство |
Baxter Oncology GmbH, Германия |
287.27 |
57.45 |
344.72 |
4% |
10 |
297.27 |
59.45 |
356.72 |
16% |
25 |
322.27 |
64.45 |
386.72 |
|
НСР-5506/23.01.2015 |
06.02.2015 |
06.02.2015 |
Неактивен |
3514 |